These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 36544389)

  • 1. Pharmacist's Knowledge and Behaviors Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process in Türkiye.
    Albayrak A; Karahalil B
    Turk J Pharm Sci; 2022 Dec; 19(6):694-700. PubMed ID: 36544389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication safety knowledge, attitude, and practice among hospital pharmacists in tertiary care hospitals in Saudi Arabia: a multi-center study.
    Al-Mutairi A; AlFayyad I; Altannir Y; Al-Tannir M
    Arch Public Health; 2021 Jul; 79(1):130. PubMed ID: 34253257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the knowledge, perception, and practice of community pharmacists in Saudi Arabia toward pharmacovigilance and adverse drug reaction reporting. A nationwide survey.
    Khardali A
    Sci Rep; 2024 Feb; 14(1):4819. PubMed ID: 38413787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Knowledge, Attitudes, and Practices about Pharmacovigilance among Community Pharmacists in Qassim, Saudi Arabia.
    Abdulsalim S; Farooqui M; Alshammari MS; Alotaibi M; Alhazmi A; Alqasomi A; Altowayan WM
    Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacovigilance Concept Knowledge, Perspectives and Attitudes: A Cross-Sectional Study Among Community Pharmacists.
    Abu Assab M; Alhamad H; Albahar F; Abu Dayyih W; Echarif S; Abu Assab H
    Inquiry; 2024; 61():469580241246464. PubMed ID: 38581250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Knowledge, Attitude and Barriers towards Pharmacovigilance among Physicians and Pharmacists of Abbottabad, Pakistan.
    Syed A; Azhar S; Raza MM; Saeed H; Jamshed SQ
    Pharmacy (Basel); 2018 Mar; 6(2):. PubMed ID: 29614725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse drug reaction reporting by community pharmacists in the Greater Accra Region of Ghana, 2016.
    Osei JY; Nortey PA; Bandoh DA; Kenu E; Addo-Lartey AA
    Ghana Med J; 2021 Mar; 55(1):9-17. PubMed ID: 38322393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug reactions (ADRS) reporting: awareness and reasons of under-reporting among health care professionals, a challenge for pharmacists.
    Shamim S; Sharib SM; Malhi SM; Muntaha SU; Raza H; Ata S; Farooq AS; Hussain M
    Springerplus; 2016; 5(1):1778. PubMed ID: 27795920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse Drug Reaction Reporting Practices Among United Arab Emirates Pharmacists and Prescribers.
    Said ASA; Hussain N
    Hosp Pharm; 2017 May; 52(5):361-366. PubMed ID: 28804153
    [No Abstract]   [Full Text] [Related]  

  • 10. A Survey of Pharmacists and Other Healthcare Professionals in Vietnam: Factors Influencing Knowledge and Attitudes Toward Reporting Adverse Drug Reactions.
    Tran V; Tran TNK; Vo QLD; Pham KAT; Dewey RS; Van CK; Dorofeeva VV
    Hosp Pharm; 2024 Feb; 59(1):56-69. PubMed ID: 38223867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the awareness and attitude of the clinicians through pharmacovigilance in Turkey.
    Aydin OC; Aydin S; Guney HZ
    World J Clin Cases; 2023 Jul; 11(20):4865-4873. PubMed ID: 37583988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacovigilance and Adverse Drug Reactions Reporting: Healthcare Providers' Experiences from Southern Highland Tanzania.
    Mwakawanga DL; Kilonzi M; Philipo EG; Martine A; Mbilinyi T; Kileo NF; Mkinga B; Shonyella CJ; Mohamedi JA; Clement A; Mwasomola D; Mushy SE; Sirili N
    Adv Pharmacol Pharm Sci; 2023; 2023():5537592. PubMed ID: 37876921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacovigilance in Italy: An overview.
    Mazzitello C; Esposito S; De Francesco AE; Capuano A; Russo E; De Sarro G
    J Pharmacol Pharmacother; 2013 Dec; 4(Suppl 1):S20-8. PubMed ID: 24347976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers to the success of an electronic pharmacovigilance reporting system in Kenya: an evaluation three years post implementation.
    Agoro OO; Kibira SW; Freeman JV; Fraser HSF
    J Am Med Inform Assoc; 2018 Jun; 25(6):627-634. PubMed ID: 29040656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse event reporting practices in drug-resistant tuberculosis facilities across South Africa.
    Gaida R; Davids AS; Sewpaul R
    S Afr J Infect Dis; 2023; 38(1):564. PubMed ID: 38223433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review of Pharmacovigilance.
    Campbell JE; Gossell-Williams M; Lee MG
    West Indian Med J; 2014 Dec; 63(7):771-4. PubMed ID: 25867582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug allergy knowledge, attitude, and practice: A survey among doctors and pharmacists in public health facilities of Sabah, Malaysia.
    Kwan MSK; Tan SL; Keowmani T; Goh SL; Voo JYH; Tan HS; Zakaria MRB; Raman S; Ho JCK; Zainullah Faidin DKB; Madi NB; Itim KB
    Asia Pac Allergy; 2023 Sep; 13(3):121-126. PubMed ID: 37744958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of education on knowledge and attitude related to pharmacovigilance and reporting of adverse drug reactions among community pharmacists in Yemen: A pre- and postinterventional study.
    Abdulwahid K; Daud NAA; Al-Worafi YM; Hassali MAA
    Perspect Clin Res; 2024; 15(2):102-103. PubMed ID: 38765543
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacovigilance: scope for a dermatologist.
    Prakash B; Singh G
    Indian J Dermatol; 2011; 56(5):490-3. PubMed ID: 22121260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addendum to: Online Reporting of Adverse Drug Reactions: A Study from a French Regional Pharmacovigilance Center - Thérapie 69 (5): 395-400 (2014) DOI: 10.2515/therapie/2014035.
    Abadie D; Chebane L; Bert M; Durrieu G; Montastruc JL
    Therapie; 2015 Oct; ():. PubMed ID: 26475752
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.